TAMPA, Fla., Sept. 16, 2005 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), a leading source of low-cost prescription medications for millions of Americans who have no prescription insurance coverage, announces today that that the company has completed the five-year financial plan.
Rx Processing Corp. completed the five-year plan to enable the company to transform itself as the prescription drug industry changes. The financial plan was completed by extracting the existing two years of actual sales data and implementing the market changing variables that will effect the prescription drug industry as the market moves to lower cost American generic prescription drugs. The strict budgeting constraints have been needed as Rx Processing Corp. strives meet quarterly and yearly goals, which include becoming a fully reporting, SEC-compliant company.
Peter Fiorillo, CEO of Rx Processing, commented, "The financial plan reassures investors that Rx Processing Corp. is committed to share holder value. The financial plan will be disseminated toward the end of 2005 in the yearly investor communications brochure."
About Rx Processing
Rx Processing is positioned to become a market leader in providing prescription drugs, lab tests and drug tests to U.S. citizens, corporations, unions, and members, through FDA-approved patient service centers, for their lab testing and licensed pharmacies in the United States and Canada. The company provides access to approved brand-name and generic medications, as well as over 1,000 lab tests through storefront locations with access to 4,000 FDA-approved patient service centers for their lab testing. Rx Processing estimates that more than 40 million Americans could benefit from the company's low-cost prescription drugs, lab testing and drug screening
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.